Overall, the data of this study suggested that miR-338-3p indeed had an inhibitive effect on neuroblastoma cell growth, invasion, and EMT process through targeting MMP-2, which provided a new potential therapeutic target in the treatment of neuroblastoma. This evidence concerns the gene MMP2 and neuroblastoma.